Citigroup Inc I Bio, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.23 - $160.0 $4,071 - $2.83 Million	-17,700 Reduced 45.32%	21,357 $4,000
Q2 2022 Aug 10, 2022	SELL	$0.23 - $0.46 $581 - $1,162	-2,527 Reduced 6.08%	39,057 $10,000
Q1 2022 May 12, 2022	SELL	$0.3 - $0.61 $10,491 - $21,331	-34,970 Reduced 45.68%	41,584 $18,000
Q4 2021 Feb 10, 2022	BUY	$0.55 - $1.04 $15,828 - $29,930	28,779 Added 60.24%	76,554 $42,000
Q3 2021 Nov 10, 2021	BUY	$1.06 - $1.52 $50,641 - $72,618	47,775 New	47,775 $51,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.